Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Matilde Sánchez-Conde
Format: Artículo científico
Language:en
Published: Sociedad Española de Farmacia Hospitalaria 2017
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1876438680812388352
author Matilde Sánchez-Conde
author_facet Matilde Sánchez-Conde
contents Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties Matilde Sánchez-Conde María-Jesús Vivancos Santiago Moreno-Guillén Medicina Pre Efficacy HIV infection exposure prophylaxis Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group. It is therefore necessary to implement alternative preventive measures for them. Pre-exposure pharmacological prophylaxis (PrEP) is one of the best evaluated options and has had high protection rates in both clinical and real-life trials. The strategy has also shown an adequate profile in terms of safety, tolerance, adverse effects and cost-effectiveness in the studies carried out to assess this important topic 2017 artículo científico 1130-6343 https://www.redalyc.org/articulo.oa?id=365962297009 https://www.redalyc.org/journal/3659/365962297009/ https://www.redalyc.org/journal/3659/365962297009/html/ https://www.redalyc.org/journal/3659/365962297009/365962297009.epub https://www.redalyc.org/journal/3659/365962297009/movil 10.7399/fh.10821 en http://www.redalyc.org/revista.oa?id=3659 Farmacia Hospitalaria application/pdf Sociedad Española de Farmacia Hospitalaria Farmacia Hospitalaria (España) Num.5 Vol.41
format Artículo científico
id redalyc_365962297009
institution Redalyc
language en
publishDate 2017
publisher Sociedad Española de Farmacia Hospitalaria
spellingShingle Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties
Matilde Sánchez-Conde
Medicina
Pre
Efficacy
HIV infection
exposure prophylaxis
Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties Matilde Sánchez-Conde María-Jesús Vivancos Santiago Moreno-Guillén Medicina Pre Efficacy HIV infection exposure prophylaxis Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group. It is therefore necessary to implement alternative preventive measures for them. Pre-exposure pharmacological prophylaxis (PrEP) is one of the best evaluated options and has had high protection rates in both clinical and real-life trials. The strategy has also shown an adequate profile in terms of safety, tolerance, adverse effects and cost-effectiveness in the studies carried out to assess this important topic 2017 artículo científico 1130-6343 https://www.redalyc.org/articulo.oa?id=365962297009 https://www.redalyc.org/journal/3659/365962297009/ https://www.redalyc.org/journal/3659/365962297009/html/ https://www.redalyc.org/journal/3659/365962297009/365962297009.epub https://www.redalyc.org/journal/3659/365962297009/movil 10.7399/fh.10821 en http://www.redalyc.org/revista.oa?id=3659 Farmacia Hospitalaria application/pdf Sociedad Española de Farmacia Hospitalaria Farmacia Hospitalaria (España) Num.5 Vol.41
title Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties
topic Medicina
Pre
Efficacy
HIV infection
exposure prophylaxis
url https://www.redalyc.org/articulo.oa?id=365962297009
https://www.redalyc.org/journal/3659/365962297009/
https://www.redalyc.org/journal/3659/365962297009/html/
https://www.redalyc.org/journal/3659/365962297009/365962297009.epub
https://www.redalyc.org/journal/3659/365962297009/movil